FindTrial
Sign In

Evaluation of use of , â??study medication â??for prophylaxis in frontline health care workers involved in treating COVID-19 patients

Prospective , multi center ,open label, pilot study on evaluation of use of , â??AyurCoro-3â?? for prophylaxis purpose in frontline health care workers involved in treating COVID-19 patients. - AyurCoro3 Prophylaxis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/10/028324
Enrollment
120
Registered
2020-10-09
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: AyurCoro-3: 10 Ml liquid , three times a day for 1 day , to be repeated every 15 days for 3 months Control Intervention1: No Comparator Agent: Not applicable

Sponsors

Bhaktivedanta Hospital and Research Institute
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Healthy frontline health care workers ,18 years and above , all genders who are involved in treating COVID-19 patients

Exclusion criteria

Exclusion criteria: 1.COVID-19 serology tests positive tests (Institute conducted it recently on all employees) . 2. Experiencing covid 19 symptoms at the time of admission . 3. Already taking some kind of prophylaxis for covid-19 at the time of study enrollment or had taken it within one month of study enrollment . 4. Working less than 3 days a week in the Hospital.

Design outcomes

Primary

MeasureTime frame
Confirmed cases of a COVID-19Timepoint: At 1 Month—

Secondary

MeasureTime frame
Confirmed cases of a COVID-19Timepoint: 3 Months—

Countries

India

Contacts

Public ContactDr Vijaykumar Gawali

Bhaktivedanta Hospital and Research Institute

drvijaykumar@bhaktivedantahospital.com9320199122

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026